115 related articles for article (PubMed ID: 2154920)
1. Nuclear DNA content, histological grade, and clinical course in patients with nonpalpable mammographically detected breast adenocarcinomas.
Azavedo E; Fallenius A; Svane G; Auer G
Am J Clin Oncol; 1990 Feb; 13(1):23-7. PubMed ID: 2154920
[TBL] [Abstract][Full Text] [Related]
2. Cytochemical classification of nonpalpable breast carcinoma.
Fallenius A; Svane G; Auer G; Caspersson TO
Anal Quant Cytol; 1983 Mar; 5(1):9-12. PubMed ID: 6303171
[TBL] [Abstract][Full Text] [Related]
3. Mammary carcinoma. Comparison of nuclear DNA content from in situ and infiltrative components.
Erhardt K; Auer GU
Anal Quant Cytol Histol; 1987 Jun; 9(3):263-7. PubMed ID: 3040031
[TBL] [Abstract][Full Text] [Related]
4. DNA ploidy in screening-detected non-palpable mammary carcinomas.
von Rosen A; Frisell J; Azavedo E; Auer G
Eur J Surg Oncol; 1990 Dec; 16(6):471-4. PubMed ID: 2174806
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of nuclear DNA analysis in histological sections in mammary carcinoma.
Erhardt K; Auer G; Fallenius A; Folin A; Forsslund G; Silfverswärd C; Zetterberg A
Am J Clin Oncol; 1986 Apr; 9(2):117-25. PubMed ID: 3012992
[TBL] [Abstract][Full Text] [Related]
6. Cytophotometrical and biochemical characterization of nonpalpable, mammographically detected mammary adenocarcinomas.
Fallenius AG; Skoog LK; Svane GE; Auer GU
Cytometry; 1984 Jul; 5(4):426-9. PubMed ID: 6468181
[TBL] [Abstract][Full Text] [Related]
7. Histopathologic and cytochemical characteristics of interval breast carcinomas from the Stockholm Mammography Screening Project.
von Rosen A; Frisell J; Nilsson R; Wiege M; Auer G
Acta Oncol; 1992; 31(4):399-402. PubMed ID: 1321649
[TBL] [Abstract][Full Text] [Related]
8. Pure and mixed mucinous breast carcinomas: DNA stemline and prognosis.
Toikkanen S; Eerola E; Ekfors TO
J Clin Pathol; 1988 Mar; 41(3):300-3. PubMed ID: 2834422
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric DNA analysis of invasive carcinomas detected by screening mammography: use of specimen mammography-guided fine-needle aspirates.
Stomper PC; DeBloom JR; Levine E; Budnick RM; Stewart CC
Clin Cancer Res; 1998 Jul; 4(7):1789-95. PubMed ID: 9676857
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric DNA analysis of excised breast lesions: use of fresh tissue needle aspirates obtained under guidance with mammography of the specimen.
Stomper PC; Stewart CC; Penetrante RB; Nava ME; Tsangaris TN
Radiology; 1992 Nov; 185(2):415-22. PubMed ID: 1329141
[TBL] [Abstract][Full Text] [Related]
11. Nuclear DNA content in mammary carcinomas in women aged 35 or younger.
von Rosen A; Fallenius A; Sundelin B; Auer G
Am J Clin Oncol; 1986 Oct; 9(5):382-6. PubMed ID: 3022573
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric DNA analysis of specimen mammography-guided fine-needle aspirates of ductal carcinoma in situ.
Stomper PC; DeBloom JR; Winston JS; Stewart CC
J Exp Clin Cancer Res; 2000 Sep; 19(3):309-15. PubMed ID: 11144524
[TBL] [Abstract][Full Text] [Related]
13. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
[TBL] [Abstract][Full Text] [Related]
14. Mammographic localization and biopsy of nonpalpable breast lesions. A 5-year study.
Thompson WR; Bowen JR; Dorman BA; Pricolo VE; Shahinian TK; Soderberg CH
Arch Surg; 1991 Jun; 126(6):730-3; discussion 733-4. PubMed ID: 1645516
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic impact of cytochemically assessed nuclear DNA contents in human adenocarcinomas of the mammary gland.
Askensten U
Arch Geschwulstforsch; 1988; 58(6):431-9. PubMed ID: 3066302
[TBL] [Abstract][Full Text] [Related]
16. Pathologic findings in nonpalpable invasive breast cancer.
McKinney CD; Frierson HF; Fechner RE; Wilhelm MC; Edge SB
Am J Surg Pathol; 1992 Jan; 16(1):33-6. PubMed ID: 1309412
[TBL] [Abstract][Full Text] [Related]
17. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
18. Treatment and survival of female patients with nonpalpable breast carcinoma.
Tinnemans JG; Wobbes T; Holland R; Hendriks JH; Van der Sluis RF; De Boer HH
Ann Surg; 1989 Feb; 209(2):249-53. PubMed ID: 2537064
[TBL] [Abstract][Full Text] [Related]
19. Stereotaxic localization for fine-needle aspiration breast biopsy. Initial experience with 300 patients.
Mitnick JS; Vazquez MF; Roses DF; Harris MN; Gianutsos R; Waisman J
Arch Surg; 1991 Sep; 126(9):1137-40. PubMed ID: 1656912
[TBL] [Abstract][Full Text] [Related]
20. Cytometry of breast carcinoma: significance of ploïdy balance and proliferation index.
Opfermann M; Brugal G; Vassilakos P
Cytometry; 1987 Mar; 8(2):217-24. PubMed ID: 3034530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
